Related Experiment Video
Updated: Sep 16, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Improving Diabetes Monitoring in People with Sub-optimally Controlled Diabetes: Implementing a Clinical
David Holland1, Ian Halsall2, Adrian H Heald3,4
1The Benchmarking Partnership, Smart Innovation Hub, Keele University, Keele, Staffordshire, ST5 5BG, UK.
Clinical laboratories can improve diabetes management by sending targeted reports to general practices. This service helps identify high-risk patients overdue for glycated haemoglobin (HbA1c) testing, leading to better glycaemic control.
Area of Science:
- Clinical Biochemistry
- Diabetes Mellitus Management
- General Practice Services
Background:
- Glycated haemoglobin (HbA1c) is the standard for assessing glycaemic status in diabetes.
- Optimal use of HbA1c testing is crucial for patient outcomes and complication minimization.
- A clinical laboratory-led service development aimed to improve follow-up for high-risk diabetes patients.
Purpose of the Study:
- To develop and evaluate a clinical laboratory-led service to facilitate targeted follow-up of high-risk patients in general practice.
- To assess the impact of monthly reports identifying patients overdue for HbA1c testing on diabetes management.
Main Methods:
- A service development involved sending monthly reports of high-risk individuals (HbA1c ≥ 58 mmol/mol) overdue for testing from a Clinical Biochemistry Laboratory to 60 general practices (Intervention group).
- A control group of 51 practices did not receive these reports (Non-intervention group).
- Comparisons were made between intervention and non-intervention groups, and pre- vs. post-intervention periods (2017-2023).
Main Results:
- The intervention group showed a significantly larger reduction in the proportion of patients overdue for testing (-20.6% vs. -10.3%, p<0.001).
- Greater improvements were observed in patients with HbA1c > 75 mmol/mol (7.8-fold larger improvement, p<0.001).
- The intervention led to improvements in median HbA1c and reduced the overall proportion of patients with HbA1c ≥ 58 mmol/mol, despite increased testing frequency.
Conclusions:
- Clinical laboratories can effectively support general practices in targeting monitoring for high-risk diabetes patients.
- Succinct reports identifying patients overdue for testing can reduce patient numbers, improve diabetes control, and increase target achievement.
- This service development demonstrates a practical approach to enhancing diabetes care through laboratory-practice collaboration.
More Related Videos
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Errors occurring during blood pressure monitoring
Several factors...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...

